Research

Rapid evidence reviews, data analysis and thought-provoking writing on the coronavirus pandemic, updated regularly by our team with international collaborators. Our reviews have informed international policy and media reporting.

Since the 1990s, the prescribing of strong pain medicines called opioids has increased in England and most high-income countries. Oxford researchers review the global and national use of opioids and have developed tools to improve patient safety.

Since 2014, the CEBM have been conducting research about the effects of neuraminidase inhibitors for treating symptoms of influenza. These activities have led to important changes in health policy and clinical practice.

This project page provides a rapid summary and evaluation of relevant data around the transmission of SARS-CoV-2, reporting on important policy implications and highlighting areas of urgently needed research.

CEBM researchers are leading research to optimise the use of anticoagulants. The work includes a suite of systematic reviews, several of which have influenced national and international health policy and clinical guidelines.

In 2014 Professor Carl Heneghan joined an undercover investigation to expose how the regulation of medical devices is so lax that mesh packaging for fruit could be approved as a medical device to be implanted in people’s bodies.

Jamie Hartmann-Boyce leads the Cochrane living systematic review of electronic cigarettes for smoking cessation, evaluating the effects of ECs to help smokers achieve long‐term abstinence.

Oral hormone pregnancy tests were given to over a million women in 20th Century, until they were withdrawn over safety concerns. Our systematic review uncovers a link between Primodos and congenital malformation.